216 related articles for article (PubMed ID: 22783684)
1. Awareness of anti-malarial policy and malaria treatment practices of patent medicine vendors in three Nigerian states.
Oladepo O; Brieger W; Adeoye B; Lawal B; Peters DH
Afr J Med Med Sci; 2011 Dec; 40(4):345-52. PubMed ID: 22783684
[TBL] [Abstract][Full Text] [Related]
2. Response of patent medicine vendors in rural areas of Lagos state Nigeria to antimalarial policy change.
Oyeyemi A; Ogunnowo B; Odukoya O
Afr Health Sci; 2015 Jun; 15(2):420-8. PubMed ID: 26124787
[TBL] [Abstract][Full Text] [Related]
3. Health workers perceptions on chloroquine and sulfadoxine/sulfalene pyrimethamine monotherapies: implications for the change to combination therapy of artemether/lumefantrine in Tanzania.
Tarimo DS; Malekela DA
East Afr J Public Health; 2007 Apr; 4(1):43-6. PubMed ID: 17907761
[TBL] [Abstract][Full Text] [Related]
4. Improvements in access to malaria treatment in Tanzania after switch to artemisinin combination therapy and the introduction of accredited drug dispensing outlets - a provider perspective.
Alba S; Hetzel MW; Goodman C; Dillip A; Liana J; Mshinda H; Lengeler C
Malar J; 2010 Jun; 9():164. PubMed ID: 20550654
[TBL] [Abstract][Full Text] [Related]
5. Drugs use pattern for uncomplicated malaria in medicine retail outlets in Enugu urban, southeast Nigeria: implications for malaria treatment policy.
Ezenduka CC; Ogbonna BO; Ekwunife OI; Okonta MJ; Esimone CO
Malar J; 2014 Jun; 13():243. PubMed ID: 24961280
[TBL] [Abstract][Full Text] [Related]
6. Accessibility, availability and affordability of anti-malarials in a rural district in Kenya after implementation of a national subsidy scheme.
Smith N; Obala A; Simiyu C; Menya D; Khwa-Otsyula B; O'Meara WP
Malar J; 2011 Oct; 10():316. PubMed ID: 22029829
[TBL] [Abstract][Full Text] [Related]
7. Poor knowledge on new malaria treatment guidelines among drug dispensers in private pharmacies in Tanzania: the need for involving the private sector in policy preparations and implementation.
Minzi OM; Haule AF
East Afr J Public Health; 2008 Aug; 5(2):117-21. PubMed ID: 19024421
[TBL] [Abstract][Full Text] [Related]
8. Impact of delayed introduction of sulfadoxine-pyrimethamine and arthemeter-lumefantrine on malaria epidemiology in KwaZulu-Natal, South Africa.
Knight SE; Anyachebelu EJ; Geddes R; Maharaj R
Trop Med Int Health; 2009 Sep; 14(9):1086-92. PubMed ID: 19624481
[TBL] [Abstract][Full Text] [Related]
9. A pharmacy too far? Equity and spatial distribution of outcomes in the delivery of subsidized artemisinin-based combination therapies through private drug shops.
Cohen JM; Sabot O; Sabot K; Gordon M; Gross I; Bishop D; Odhiambo M; Ipuge Y; Ward L; Mwita A; Goodman C
BMC Health Serv Res; 2010 Jul; 10 Suppl 1(Suppl 1):S6. PubMed ID: 20594372
[TBL] [Abstract][Full Text] [Related]
10. The role of private drug vendors as malaria treatment providers in selected malaria endemic areas of Sri Lanka.
Rajakaruna RS; Weerasinghe M; Alifrangis M; Amerasinghe PH; Konradsen F
J Vector Borne Dis; 2006 Jun; 43(2):58-65. PubMed ID: 16967817
[TBL] [Abstract][Full Text] [Related]
11. Piloting the global subsidy: the impact of subsidized artemisinin-based combination therapies distributed through private drug shops in rural Tanzania.
Sabot OJ; Mwita A; Cohen JM; Ipuge Y; Gordon M; Bishop D; Odhiambo M; Ward L; Goodman C
PLoS One; 2009 Sep; 4(9):e6857. PubMed ID: 19724644
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting treatment practices of patent medicine vendors for malaria in under-five children: implications for malaria control in Nigeria.
Ihesie CA; Johnson OE; Motilewa OO; Umoren QM
Ghana Med J; 2019 Sep; 53(3):237-247. PubMed ID: 31741496
[TBL] [Abstract][Full Text] [Related]
13. Stocking pattern for anti-malarial medications among proprietary patent medicine vendors in Akinyele Local Government Area, Ibadan, Nigeria.
Kodaolu MY; Fagbamigbe AF; Ajayi IO
Malar J; 2020 Aug; 19(1):279. PubMed ID: 32746914
[TBL] [Abstract][Full Text] [Related]
14. Progress toward elimination of malaria in Nigeria: uptake of artemisinin-based combination therapies for the treatment of malaria in households in Benin City.
Akoria OA; Arhuidese IJ
Ann Afr Med; 2014; 13(3):104-13. PubMed ID: 24923369
[TBL] [Abstract][Full Text] [Related]
15. Does the consent of the patients have a role to play in formulating a treatment policy?
Kango M; Baboo KS
Trop Doct; 2008 Jan; 38(1):56-7. PubMed ID: 18302874
[TBL] [Abstract][Full Text] [Related]
16. A rural-urban comparison of client-provider interactions in patent medicine shops in South west Nigeria.
Fajola A; Asuzu MC; Owoaje ET; Asuzu CC; Ige OK; Oladunjoye OO; Asinobi A
Int Q Community Health Educ; 2011-2012; 32(3):195-203. PubMed ID: 23353561
[TBL] [Abstract][Full Text] [Related]
17. The association between price, competition, and demand factors on private sector anti-malarial stocking and sales in western Kenya: considerations for the AMFm subsidy.
O'Meara WP; Obala A; Thirumurthy H; Khwa-Otsyula B
Malar J; 2013 Jun; 12():186. PubMed ID: 23738604
[TBL] [Abstract][Full Text] [Related]
18. Access to subsidized artemether-lumefantrine from the private sector among febrile children in rural setting in Kilosa, Tanzania.
Simba D; Kakoko D
Tanzan J Health Res; 2012 Apr; 14(2):89-95. PubMed ID: 26591729
[TBL] [Abstract][Full Text] [Related]
19. A qualitative study of the feasibility and community perception on the effectiveness of artemether-lumefantrine use in the context of home management of malaria in south-west Nigeria.
Ajayi IO; Falade CO; Olley BO; Yusuf B; Gbotosho S; Iyiola T; Olaniyan O; Happi C; Munguti K; Pagnoni F
BMC Health Serv Res; 2008 Jun; 8():119. PubMed ID: 18513447
[TBL] [Abstract][Full Text] [Related]
20. Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!
Mutabingwa TK
Acta Trop; 2005 Sep; 95(3):305-15. PubMed ID: 16098946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
